Brazil hits 82,000 Covid deaths in April, new monthly record

Credit: Unsplash / CC0 Public Domain

Brazil recorded 2,595 new deaths from COVID-19 on Friday, bringing the total for April to 82,266. This is the second consecutive monthly record as the country has been grappling with a devastating surge since the start of the year.

According to the Ministry of Health, 66,573 deaths were recorded in March, underscoring the sharp rise in deaths in recent weeks.

At 212 million people, the death toll in Brazil in the pandemic exceeded 400,000 on Thursday and one of the highest death rates at 189 deaths per 100,000 population.

The country is seeking more vaccines and the Senate is investigating whether President Jair Bolsonaro’s administration has exacerbated the crisis.

Hospitals have been pushed to the brink of collapse in many areas, although experts say the peak of the new wave appears to be over.

Experts attribute the recent surge in part to the Brazilian variant of the virus, a mutation that emerged in or around the Amazon rainforest city of Manaus in December.

Known as P1, it can re-infect people who had the original strain of the virus and potentially be more contagious.

Around 29 million people in Brazil have received an initial dose of COVID-19 vaccine, over 13 percent of the population. About 13 million received a second.

According to TV Globo, cities in 14 of the 27 Brazilian states had to suspend the second dose due to bottlenecks.

Bolsonaro controversially downplayed the virus, taken steps to contain it, and turned down some vaccine offers.

The far-right president has defended his handling of the pandemic and told supporters: “I was not wrong about anything.”

Follow the latest news on the Coronavirus (COVID-19) outbreak

© 2021 AFP

Quote: Brazil recorded 82,000 Covid deaths in April. The new monthly record (2021, May 1st) was accessed on May 1st, 2021 from https://medicalxpress.com/news/2021-05-brazil-covid-deaths-april-monthly.html

This document is subject to copyright. Except for fair trade for the purpose of private study or research, no part may be reproduced without written permission. The content is provided for informational purposes only.